Palantir Bounces 13% on Nvidia Deal and Army Win, Yet Remains 37% Below Peak Amid European Pushback
Published on 07/04/2026 at 14:44 | Redaktion boerse-global.de
A near-13 percent weekly surge catapulted Palantir Technologies back into the spotlight, but the stock is still nursing a 21 percent year-to-date loss. Closing Friday at €112.28, the shares snapped a prolonged slide — yet the gap between the one-week adrenaline shot and the six-month hangover tells a more nuanced story. Palantir has become a proxy for the brutal transition from AI hype to monetisation, and its daily swings are anything but calm.
The latest leg up was sparked by a cluster of strategic moves. Chief Executive Alex Karp took direct aim at rival pricing models, questioning the long-term viability of token-based systems from Anthropic and OpenAI. He argues that customers are wary of being locked into dominant foundation models. That narrative dovetailed with a deepened partnership with Nvidia, which will integrate Nvidia’s open-source Nemotron models into Palantir’s AIP and Foundry platforms to build sovereign AI solutions for government clients. Analysts took note: Gil Luria raised his rating, calling the recent selloff an entry point, with Palantir acting as the conductor for multiple AI models rather than a single orchestra.
The military dimension added real heft. The US Army selected Palantir Foundry as the data layer for its Next Generation Command and Control (NGC2) programme. This follows a $100 million prototype award in July 2025 to the Anduril-Palantir team, and operates under an existing ten-year licensing agreement between the Army and Anduril that allows for up to $20 billion in total value. For investors, that kind of multi-year, mission-critical contract provides revenue visibility that short-term price action often masks.
Should investors sell immediately? Or is it worth buying Palantir?
Operational metrics reinforce the case. Palantir’s Rule of 40 — a blend of revenue growth and profit margin widely used in software investing — hit 145 percent in the first quarter of 2026, propelled by 85 percent revenue growth and expanding operating margins. Those numbers are rare even in the hot AI sector, and management expects the commercial segment to eventually overtake government business. Yet the market capitalisation of €263.41 billion leaves no room for execution stumbles.
On the charts, the stock is far from out of the woods. It trades 37.57 percent below its 52-week high of €179.98 set on 3 November 2025. The 200-day moving average sits at €134.60, while the 50-day moving average is at €115.34 — the shares hugged that line on Friday. The 14-day relative strength index of 51.8 points to neutral territory, neither overbought nor oversold. Technical analysts note that a clean break above €135 would be needed to confirm a trend reversal, but for now bulls and bears cancel each other out.
Political headwinds in Europe are providing a persistent drag. Reports indicate that the Spanish government has told state-linked entities to avoid new contracts with Palantir over national sovereignty concerns. In the United Kingdom, the company faces ongoing protests and local council resistance stemming from its involvement in the NHS Federated Data Platform. These developments have kept the stock in negative territory on a twelve-month basis, down 1.7 percent.
The average analyst price target of €159.71 implies a potential upside of 42.1 percent, but that depends on whether the story of sovereign AI can outweigh the valuation premium and political friction. With next quarterly earnings still weeks away, pure sentiment is driving the daily tape. The annualised volatility of 64 percent is extraordinary for a company of Palantir’s size, and it will likely remain the defining feature of the trade until fundamentals deliver a clearer verdict.
Ad
Palantir Stock: New Analysis - 4 July
Fresh Palantir information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
